Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

TNF-alpha-inhibitory thiazolopyrimidines patented by group at U. of California

Jan. 5, 2001

Chemokine inhibitors described by Teijin for rheumatoid arthritis and other disorders

Jan. 5, 2001

Compounds promoting proteoglycan production claimed by Sumitomo

Jan. 5, 2001

Recombinant AnergiX.RA to be codeveloped by Corixa and Organon

Jan. 5, 2001

Recent patent covers MMP and TACE inhibitors from Fuji Yakuhin

Jan. 4, 2001

Therapeutically useful metalloproteinase inhibitors designed at Darwin Discovery

Jan. 4, 2001

Hydroxamic acid-based MMP inhibitors with selectivity for MMP-2, MMP-9 and/or MMP-13

Jan. 3, 2001

Remicade is first drug approved for inhibiting progression of joint damage in RA

Jan. 3, 2001

BP-2-94: an H3 receptor agonist prodrug with an interesting antiinflammatory/antinociceptive profile

Jan. 2, 2001

Abgenix's ABX-IL-8 enters phase II evaluation for rheumatoid arthritis

Dec. 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...